Literature DB >> 3793874

Mycobacterium haemophilum infection in a patient with acquired immune deficiency syndrome.

B M Males, T E West, W R Bartholomew.   

Abstract

Mycobacterium haemophilum was isolated from wrist and ankle aspirates as the organism responsible for tenosynovitis in a patient with acquired immune deficiency syndrome. Mycobacterium isolates recovered from synovial fluid were identified as hemin requiring by their failure to grow on subculture unless the medium was supplemented with hemin. M. haemophilum is of low virulence and rarely associated with infections in humans. This is the first documented case of M. haemophilum infection in a patient with acquired immune deficiency syndrome.

Entities:  

Mesh:

Year:  1987        PMID: 3793874      PMCID: PMC265858          DOI: 10.1128/jcm.25.1.186-190.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  The antagonism of the tuberculostatic action of isoniazid by Hemin.

Authors:  M W FISHER
Journal:  Am Rev Tuberc       Date:  1954-03

2.  Virulence of Mycobacterium tuberculosis: evaluation of a test, using neutral red indicator.

Authors:  D E HUGHES; E S MOSS; M HOOD; M HENSON
Journal:  Am J Clin Pathol       Date:  1954-05       Impact factor: 2.493

3.  Chaetoconidium and atypical acid-fast bacilli in skin ulcers.

Authors:  S Lomwardias; G E Madge
Journal:  Arch Dermatol       Date:  1972-12

4.  Identification of Mycobacterium kansasii by susceptibility to hydroxylamine.

Authors:  H Gruft; M Osterhout
Journal:  Appl Microbiol       Date:  1970-01

5.  The skin and immunosuppression.

Authors:  B K Walder; D Jeremy; J A Charlesworth; G J Macdonald; B A Pussell; M R Robertson
Journal:  Australas J Dermatol       Date:  1976-12       Impact factor: 2.875

6.  Mycobacterial skin infection by an unidentified species. A report of 29 patients.

Authors:  R A Feldman; E Hershfield
Journal:  Ann Intern Med       Date:  1974-04       Impact factor: 25.391

7.  Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics.

Authors:  T E Kiehn; F F Edwards; P Brannon; A Y Tsang; M Maio; J W Gold; E Whimbey; B Wong; J K McClatchy; D Armstrong
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

8.  Radiometric studies with gas-liquid and thin-layer chromatography for rapid demonstration of hemin dependence and characterization of Mycobacterium haemophilum.

Authors:  J J Damato; M T Collins
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

9.  Use of lysis-centrifugation (isolator) and radiometric (BACTEC) blood culture systems for the detection of mycobacteremia.

Authors:  V J Gill; C H Park; F Stock; L L Gosey; F G Witebsky; H Masur
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

10.  Continuous high-grade mycobacterium avium-intracellulare bacteremia in patients with the acquired immune deficiency syndrome.

Authors:  B Wong; F F Edwards; T E Kiehn; E Whimbey; H Donnelly; E M Bernard; J W Gold; D Armstrong
Journal:  Am J Med       Date:  1985-01       Impact factor: 4.965

View more
  20 in total

1.  Ghost mycobacteria on Gram stain.

Authors:  S Trifiro; A M Bourgault; F Lebel; P René
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

Review 2.  HIV-Related Skin Disease in the Era of Antiretroviral Therapy: Recognition and Management.

Authors:  Khatiya Chelidze; Cristina Thomas; Aileen Yenting Chang; Esther Ellen Freeman
Journal:  Am J Clin Dermatol       Date:  2019-06       Impact factor: 7.403

Review 3.  Agents of newly recognized or infrequently encountered mycobacterial diseases.

Authors:  L G Wayne; H A Sramek
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

4.  Optimal detection and identification of Mycobacterium haemophilum in specimens from pediatric patients with cervical lymphadenopathy.

Authors:  Z Samra; L Kaufmann; A Zeharia; S Ashkenazi; J Amir; J Bahar; U Reischl; L Naumann
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

Review 5.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

6.  Evaluation of an extended blood culture protocol to isolate fastidious organisms from patients with AIDS.

Authors:  M J Dougherty; D H Spach; A M Larson; T M Hooton; M B Coyle
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

7.  Rapid identification using a specific DNA probe of Mycobacterium avium complex from patients with acquired immunodeficiency syndrome.

Authors:  T E Kiehn; F F Edwards
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

8.  Direct identification of Mycobacterium haemophilum in skin lesions of immunocompromised patients by PCR-restriction endonuclease analysis.

Authors:  S X Wang; L H Sng; H N Leong; B H Tan
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

Review 9.  Mycobacterium haemophilum: an emerging pathogen.

Authors:  T E Kiehn; M White
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

10.  Laboratory aspects of "Mycobacterium genavense," a proposed species isolated from AIDS patients.

Authors:  M B Coyle; L C Carlson; C K Wallis; R B Leonard; V A Raisys; J O Kilburn; M Samadpour; E C Böttger
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.